Kolibri is a full service digital agency founded in 2007 and headquartered in Iceland. The company's slogan, "Þróum það besta í fólki og fyrirtækjum," reflects its mission to help brands create impact by delivering websites, apps, and digital experiences that are friendly to humans and businesses alike. Specializing in industries such as Biopharma, Biotechnology, and Manufacturing, Kolibri employs designers, developers, researchers, and agile coaches, focusing on combining creativity and craftsmanship with the correct strategies. In its most recent development, Kolibri secured a Seed Round investment on 06 March 2023, with Creative Ventures as the participating investors.
Kolibri
Þróum það besta í fólki og fyrirtækjum.
Founded 2007
Iceland
37 employees
Convertible Note
Biopharma, Biotechnology +1
Iceland
37 employees
Convertible Note
Biopharma, Biotechnology +1
General Information
Company Name
Kolibri
Founded Year
2007
Location
Iceland
Iceland
Employees
37
Industries
Biopharma, Biotechnology, Manufacturing
Funding Stage
Convertible Note
BounceWatch is an independent company data service, not affiliated with Kolibri. To contact Kolibri, visit kolibri.is.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Kolibri compare?
A PDF of Kolibri and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Kolibri soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Iceland Market
Biopharma
About Kolibri
Business keywords: bioreactors, cell density, acoustic wave technology, cell engineering, drug development, gene therapies, AAV gene therapy, cell-based therapies, cellular agriculture, scale-up technology
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | Undisclosed | 1 |
|
06 Mar 2023 |
| Non Equity Assistance | Undisclosed | 1 |
BioTools Innovator
|
06 Jul 2022 |
| Seed Round | Undisclosed | 2 |
|
13 Apr 2021 |
Kolibri Alternatives & Competitors
View All Alternatives
Kolibri vs
Ethris
Germany
Clinical stage biotech company focused on development of disruptive mRNA therapeutics for severe res...
Venture round
34 employees
Biopharma, Biotechnology
Kolibri vs
ProBio
United States
Manufacturing Life-Changing Therapies
Series C
246 employees
Biopharma, Biotechnology
Kolibri vs
FAQ About Kolibri
Þróum það besta í fólki og fyrirtækjum.
Kolibri was founded in 2007.
Kolibri is headquartered in Iceland.
Kolibri operates in Biopharma, Biotechnology and Manufacturing. Its work centres on bioreactors, cell density, acoustic wave technology and cell engineering.
Kolibri has approximately 37 employees.
Kolibri has completed 3 funding rounds. The latest funding stage is Convertible Note.
Top alternatives and competitors to Kolibri include Ethris, ProBio, Membio Inc., Indee Labs, Ascend Advanced Therapies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Kolibri and Ethris are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for Kolibri, https://bouncewatch.com/company/kolibri, updated 26 December 2024. When citing, please name BounceWatch and link this page.
